Dosing regimen differentiates sensitization of locomotion and mouthing to D2 agonist quinpirole

This publication has 14 references indexed in Scilit:

• Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systematic amphetamine
  Brain Research, 1989
• D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements
  Brain Research, 1989
• Biphasic effect of D-2 agonist quinpirole on locomotion and movements
  European Journal of Pharmacology, 1989
• Characteristics of “reverse tolerance” to amphetamine-induced locomotor stimulation in mice
  Neuropharmacology, 1988
• Time‐dependent sensitization as the cornerstone for a new approach to pharmacotherapy: Drugs as foreign/stressful stimuli
  Drug Development Research, 1988
• Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors
  European Journal of Pharmacology, 1986
• Behavioral effects of a single neuroleptic treatment grow with the passage of time
  Brain Research, 1986
• Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393
  Neuropharmacology, 1986
• Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
  Brain Research Reviews, 1986
• Intermittent versus continuous stimulation: Effect of time interval on the development of sensitization or tolerance
  Life Sciences, 1980